Market Insights:
The Global Medical Smart Textile Market is expected to register a CAGR of 7.51% to reach 2,105.32 Million by 2027. Medical smart textile is a new field of research and is most widely used in the healthcare sector. Sensors are integrated into the textiles, in continuous contact with the human body, and could capture physiological changes occurring within the body. The demand for medical smart textiles is increasing due to the rising burden of diseases, evolving methods of diagnosis, and extensive use of wearable medical devices. These factors are expected to fuel the growth of the global medical smart textile market. However, the high cost of smart textiles is anticipated to hamper the market growth.
Key Players
The global medical smart textile market overview by Market research Future contains The top prominent players like Schoeller Switzerland, Vista Medical Ltd, Sensoria Inc., Gentherm, Siren, Pireta, AiQ Smart Clothing, Camira Fabrics, Carre Technologies Inc, and 3teks.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1123
Some of the key strategies followed by players operating in the global medical smart textile market were innovation, product development, and acquisition & mergers.
- In February 2019, Gentherm signed a partnership agreement with ThermoAnalytics, Inc., a leading thermal modeling software development firm for the advancement of human thermal comfort predictions.
- In June 2019, Pireta developed a unique process that adds conductive metallic pattern directly into textile clothing without changing the fabric feel. These wearable smart garments and e-textile enabled physicians to diagnose diseases in their early stages and provide better treatment options. The launch of this device would help the company to increase its revenue in the future.
- In July 2019, Camira Fabric acquired Luna Textiles, a US-based company that manufactures fabric for healthcare, hospitality, and other lounge seating purposes. This acquisition helped Camira Fabric to increase its revenue.
Market Dynamics
The rising burden of diseases is expected to fuel the growth of the global medical smart textile market during the forecast period. According to the Global Burden of Disease Study in 2017, from 1990 to 2017, the leading causes of premature deaths were neonatal disorders, ischemic heart disease, lower respiratory infections, diarrhea, chronic obstructive pulmonary disease (COPD), and strokes. These diseases accounted for more than 1 million deaths worldwide in 2017. Additionally, the Global Burden of Disease Study in 2017, stated that there was a change in the mortality rate due to excess drug-resistant tuberculosis from 2007 to 2017.
Segmentation
The global medical smart textile market has been segmented by technology, application, and end user. The market, based on technology, has been divided into wearable technology, textile sensors, and others. Based on application, the medical smart textile market has been segregated into bio-monitoring, surgery, therapy, and wellness and others. The global medical smart textile market, based on end user, has been bifurcated into hospitals and clinics and others. The hospitals and clinics held a share of 67.3% in 2018.
Regional Market Summary
The global medical smart textile market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to dominate the global medical smart textile market. The growth in this region can be attributed to the extensive use of medical devices. Moreover, applications in medical engineering for monitoring vital health indicators help in maximizing the growth of the market in this region. Europe held a substantial share in the global medical smart textile market. This can be attributed to the rising government expenditure to promote the healthcare sector in the region. For instance, according to Eurostat, in 2016, healthcare expenditure per person was EUR 5,000 or higher in three EU member states that are Luxembourg (EUR 5,600), Sweden (EUR 5,100) and Denmark (EUR 5,000), as the per-person healthcare expenditure is very high in Europe and is continuously growing. Asia-Pacific is estimated to be the fastest-growing region in the global market. This is due to the extensive demand for advanced medical devices and increasing applications of technology in the early diagnosis of diseases fueling the growth of the medical smart textile market in the region. The medical smart textile market in the Middle East & Africa is expected to witness a modest market growth rate from 2019 to 2027. The Middle East would lead the market growth in this region. Increasing awareness about medical smart textiles is expected to drive market growth during the assessment period.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-smart-textile-market-1123
Prescribed Health Apps Market Research By Operating System( Windows, Androids, iPhones ) By Devices ( Diabetes management device, multi-parameter tracker, cardiac monitoring device ) and End User Analysis By New Technology, Trends and Global Industry Forecast to 2024The Prescribed Health Apps Market report offers insights into the leading market players and presents an assessment of their current market position.
Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, MA activities, and the latest RD initiatives is also available in the reportMajor Key PlayersThe key strategies followed by the players operating in the global Prescribed Health Apps Market were innovation, product development, acquisition, and expansion.iHealth Lab, Inc.BioTelemetry Inc.,AirStrip Technologies, Apple, Inc. Sanofi, LifeWatch AG, etc.. Market Segment AnalysisThe Prescribed Health apps market is divided into following segmentsSegmentation by type Operating System-iPhones-Androids-Windows-OthersSegmentation by Devices-Diabetes management device-multi-parameter tracker-cardiac monitoring device-Others Top of FormKey Study Highlights:This report for Prescribed Health Apps Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.
The report also gives a broad study of the different market segments and regions.Regional AnalysisGeographically, the global Prescribed Health Apps Market has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.Browse Full Report Page Enabled with complete Table of Content at https://www.marketresearchfuture.com/reports/global-prescribed-health-apps-market-758 Chapter 9.
Global Prescribed Health Apps Market By Region9.1 Introduction9.2 America9.2.1 North America9.2.1.1 U.S.9.2.1.2 Canada9.2.2 South America9.3 Europe9.3.1 Western Europe9.3.1.1 Germany9.3.1.2 France9.3.1.3 Italy9.3.1.4 Spain9.3.1.5 U.K.9.3.1.6 Rest Of Western Europe9.3.2 Eastern Europe9.4 Asia Pacific9.4.1 Japan9.4.2 China9.4.3 India9.4.4 Australia9.4.5 Republic Of Korea9.4.6 Rest Of Asia Pacific9.5 The Middle East Africa9.5.1 United Arab Emirates9.5.2 Saudi Arabia9.5.3 Oman9.5.4 Kuwait9.5.5 Qatar9.5.6 Rest Of The Middle East AfricaAbout Market Research Future: MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.Contact:+1 646 845 9312 | Email: [email protected]
The growing preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting the growth of the market.
However, the growth of the market is likely to be restrained by factors such as the high cost of instruments, restrictions on reagent use, and the lack of infrastructure for cell-based research in emerging economies.
The cell-based assays market is projected to reach USD 22.0 billion by 2025 from USD 14.9 billion in 2020, at a CAGR of 8.1% during the forecast period.Cell-based Assays Market DynamicsDriver: Growing preference for cell-based assays in drug discoveryCell-based assays are key components in the drug development process.
They offer consistent tissue-specific responses in a biologically relevant microenvironment as opposed to biochemical assays.
It is also not possible to prepare or purify every target for biochemical measurement, which is a major factor limiting the applications of biochemical assays.To know about the assumptions considered for the study, download the pdf brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119917269The conventional methods of toxicity and drug safety assessment (involving animal testing) are expensive, time-consuming, and offer low-throughput.
In this regard, modern cell-based assays merge the advantages of cell cultures and animal models to allow researchers to identify problems with lead compounds in early screening, ensuring greater efficiency in the drug discovery and development process.Resatraint: High cost of instruments and restrictions on reagent useThe introduction of high-throughput screening (HTS) and high-content screening (HCS) technologies in cell-based assays has increased their reliability.
Network Airline Management (NAM) and Kuehne+Nagel have renewed their long-term freighter aircraft contract by a further 12 months, sealing their ongoing partnership into 2021.https://www.logupdateafrica.com/nam-kuehnenagel-renew-freighter-aircraft-agreement--aviation
